Remove Genetics and mental health Remove Manufacturing Remove Pharmaceuticals
article thumbnail

Critical Psychiatry Textbook, Chapter 16: Is There Any Future for Psychiatry? (Part Six)

Mad in America

Schatzberg has served as a consultant to or received honoraria from Abbott, Bristol-Myers Squibb, Corcept Therapeutics, Forest Laboratories, Janssen, Eli Lilly, Merck, Mitsubishi Pharmaceuticals, Organon, ParkeDavis, Pfizer, Pharmacia–Upjohn, Sanofi, Scirex, SmithKline Beecham, Solvay, and Wyeth–Ayerst. 695 This is sickening.

article thumbnail

The Clinical, Social, and Cultural Harm of an Iatrogenic Psychiatry

Mad in America

Iatrogenesis is social when medicine as an institution and a bureaucracy creates ill-health by increasing stress; by subverting autonomy and community support; and by depoliticizing sources of illness. This alienation is of course quite stressful and a source of ill-health. The natural course of depression without any medication?

article thumbnail

Branding Diseases—How Drug Companies Market Psychiatric Conditions: An Interview with Ray Moynihan

Mad in America

R ay Moynihan is an accomplished health journalist and author who has won several awards for his work. For the pharmaceutical industry, the bigger and wider those diseases, the more people who can be diagnosed, and the bigger your markets are. This applies in the mental illness world and everywhere in medicine.